Cargando…
Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers
BACKGROUND: Dyslipidemia in metabolic syndrome may introduce an underestimation of the risk for cardiovascular disease (CVD) using Low-Density Lipoprotein-Cholesterol (LDL-C) as a surrogate marker. Recently, non-High-Density Lipoprotein-Cholesterol (non-HDL-C), Apolipoprotein B (ApoB) and remnant-Ch...
Autores principales: | Bergström, Helena, Ekström, Lena, Warnqvist, Anna, Bergman, Peter, Björkhem-Bergman, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058971/ https://www.ncbi.nlm.nih.gov/pubmed/33879161 http://dx.doi.org/10.1186/s12905-021-01306-4 |
Ejemplares similares
-
Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β‐hydroxycortisol/cortisol
por: Bergström, Helena, et al.
Publicado: (2021) -
Urinary steroid profile in relation to the menstrual cycle
por: Schulze, Jenny, et al.
Publicado: (2020) -
Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men
por: Gårevik, Nina, et al.
Publicado: (2014) -
Vitamin D binding protein is not affected by high-dose vitamin D supplementation: a post hoc analysis of a randomised, placebo-controlled study
por: Björkhem-Bergman, Linda, et al.
Publicado: (2018) -
Vitamin D receptor rs2228570 polymorphism is associated with LH levels in men exposed to anabolic androgenic steroids
por: Björkhem-Bergman, Linda, et al.
Publicado: (2018)